blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2556088

EP2556088 - PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS) [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.10.2014
Database last updated on 22.08.2024
Most recent event   Tooltip24.10.2014Application deemed to be withdrawnpublished on 26.11.2014  [2014/48]
Applicant(s)For all designated states
Universitätsspital Basel
Hebelstrasse 32
4031 Basel / CH
[2013/07]
Inventor(s)01 / KAPPOS, Ludwig
Burgstrasse 57
CH-4125 Riehen / CH
02 / KUHLE, Jens
Amselstrasse 29
CH-4104 Oberwil / CH
 [2013/07]
Representative(s)Peter, Beate, et al
CSL Behring Patents & Licenses Emil-von-Behring-Strasse 76
35041 Marburg / DE
[2013/07]
Application number, filing date11714260.408.04.2011
WO2011EP55480
Priority number, dateEP2010000376208.04.2010         Original published format: EP 10003762
[2013/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011124668
Date:13.10.2011
Language:EN
[2011/41]
Type: A1 Application with search report 
No.:EP2556088
Date:13.02.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 13.10.2011 takes the place of the publication of the European patent application.
[2013/07]
Search report(s)International search report - published on:EP13.10.2011
ClassificationIPC:C07K16/00, A61P37/00
[2013/07]
CPC:
C07K16/00 (EP,US); A61K39/39516 (US); A61P37/00 (EP);
A61P37/02 (EP); A61P39/00 (EP); C07K16/2842 (EP,US);
A61K2039/505 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/07]
TitleGerman:AUS PLASMA STAMMENDES IMMUNGLOBULIN ZUR VERWENDUNG BEI DER BEHANDLUNG UND PRÄVENTION VON INFLAMMATORISCHEN IMMUNREKONSTITUTIONSSYNDROM (IRIS)[2013/07]
English:PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS)[2013/07]
French:IMMUNOGLOBULINE ISSUE DU PLASMA POUR L'UTILISATION DANS LE TRAITEMENT ET LA PRÉVENTION DU SYNDROME INFLAMMATOIRE DE RECONSTITUTION IMMUNE (IRIS)[2013/07]
Entry into regional phase08.11.2012National basic fee paid 
08.11.2012Designation fee(s) paid 
08.11.2012Examination fee paid 
Examination procedure02.11.2012Amendment by applicant (claims and/or description)
08.11.2012Examination requested  [2013/07]
06.12.2013Despatch of a communication from the examining division (Time limit: M06)
17.06.2014Application deemed to be withdrawn, date of legal effect  [2014/48]
11.07.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/48]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.12.2013
Fees paidRenewal fee
02.05.2013Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.04.201404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]  - CLIFFORD DAVID B ET AL, "Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.", LANCET NEUROLOGY APR 2010 LNKD- PUBMED:20298967, (20100316), vol. 9, no. 4, ISSN 1474-4465, pages 438 - 446, XP026969520 [X] 1-4,7-17 * abstract; table 2 * [I] 5,6
 [I]  - MURDOCH DAVID M ET AL, "Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.", AIDS RESEARCH AND THERAPY 2007 LNKD- PUBMED:17488505, (2007), vol. 4, ISSN 1742-6405, page 9, XP021025355 [I] 5,6 * whole document, in particular abstract *

DOI:   http://dx.doi.org/10.1186/1742-6405-4-9
 [A]  - BEISHUIZEN S J E ET AL, "Immune reconstitution inflammatory syndrome: immunopathogenesis, risk factors, diagnosis, treatment and prevention", NETHERLANDS JOURNAL OF MEDICINE, (200911), vol. 67, no. 10, ISSN 0300-2977, pages 327 - 331, XP009137248 [A] 1-17 * abstract *
 [A]  - TAN CHEN S ET AL, "Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.", LANCET NEUROLOGY APR 2010 LNKD- PUBMED:20298966, (20100316), vol. 9, no. 4, ISSN 1474-4465, pages 425 - 437, XP026969519 [A] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/S1474-4422(10)70040-5
 [A]  - BRETON GUILLAUME, "[Immune reconstitution inflammatory syndrome or IRIS]", MÉDECINE SCIENCES : M/S MAR 2010 LNKD- PUBMED:20346278, (201003), vol. 26, no. 3, ISSN 0767-0974, pages 281 - 289, XP009137287 [A] 1-17 * the whole document *
 [A]  - ACHIRON ANAT ET AL, "Intravenous immunoglobulin and multiple sclerosis.", CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY DEC 2005 LNKD- PUBMED:16391400, (200512), vol. 29, no. 3, ISSN 1080-0549, pages 247 - 254, XP009137291 [A] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1385/CRIAI:29:3:247
 [A]  - LANGER-GOULD ANNETTE ET AL, "Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab", NEW ENGLAND JOURNAL OF MEDICINE, THE, MASSACHUSETTS MEDICAL SOCIETY, WALTHAM, MA, US, (20050728), vol. 353, no. 4, ISSN 0028-4793, pages 375 - 381, XP009123696 [A] 1-17 * the whole document *
 [A]  - LIPMAN MARC ET AL, "Immune reconstitution inflammatory syndrome in HIV.", CURRENT OPINION IN INFECTIOUS DISEASES FEB 2006 LNKD- PUBMED:16374213, (200602), vol. 19, no. 1, ISSN 0951-7375, pages 20 - 25, XP009137245 [A] 1-17 * abstract *

DOI:   http://dx.doi.org/10.1097/01.qco.0000200543.80712.01
by applicantWO2008083680
    - WAGNER, Z. RHEUMATOL., (2008), vol. 67, pages 284 - 289
    - BEIZHUISEN, GEERLINGS, THE NETHERLANDS JOURNAL OF MEDICINE, (2009), vol. 67, pages 327 - 332
    - HENDERSON ET AL., BR. J. OPHTALMOL, (1999), vol. 83, pages 540 - 545
    - SINGH ET AL., TRANSPLANTATION, (2005), vol. 80, pages 1131 - 1133
    - ALON R ET AL., J CELL BIOL, (1995), vol. 128, no. 6, pages 1243 - 1253
    - JOHNSTON B, KUBES P., IMMUNOL TODAY, (1999), vol. 20, no. 12, pages 545 - 550
    - ARROYO AG ET AL., CELL, (1996), vol. 85, no. 7, pages 997 - 1008
    - COISNE C ET AL., J IMMUNOL, (2009), vol. 182, no. 10, pages 5909 - 5913
    - POLMAN CH ET AL., N ENGL J MED, (2006), vol. 354, no. 9, pages 899 - 910
    - RUDICK RA, PANZARA MA., BIOLOGICS, (2008), vol. 2, no. 2, pages 189 - 199
    - KNOWLES WA ET AL., J MED VIROL, (2003), vol. 71, no. 1, pages 115 - 123
    - WENNING ET AL., N. ENGL. J. MED., (2009), vol. 361, pages 1075 - 1080
    - CARSON ET AL., LANCET ONCOLOGY, (2009), vol. 10, pages 816 - 823
    - ALLISON ET AL., NAT. BIOTECH., (2010), vol. 28, pages 105 - 106
    - LANGER-GOULD ET AL., N, ENGL. J. MED., (2005), vol. 353, pages 375 - 381
    - PADATE ET AL., CLIN. LAB. HAEM., (2006), vol. 28, pages 69 - 71
    - STROVE ET AL., ARCH. NEUROL., (2007), page 64
    - AHMED ET AL., N. ENGL. J. MED., (2006), vol. 355, pages 1772 - 1778
    - COOPER ET AL., BRITISH JOURNAL OF HEMATOLOGY, (2009), vol. 146, pages 120 - 122
    - HARTUNG ET AL., CLIN. EXP. IMMUNOL., (2009), vol. 158, no. 1, pages 23 - 33
    - SHARMA ET AL., BLOOD, (2000), vol. 96, pages 1184 - 1186
    - K6HLER, MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497
    - KOZBOR, IMMUNOLOGY TODAY, (1983), vol. 4, page 72
    - COLE ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, INC., (1985), pages 77 - 96
    - CROWDER CD ET AL., AM J TRANSPLANT, (2005), vol. 5, no. 5, pages 1151 - 1158
    - SHITRIT D ET AL., TRANSPL INT, (2005), vol. 17, no. 11, pages 658 - 665
    - KAPPOS L ET AL., LANCET NEUROL, (2007), vol. 6, no. 5, pages 431 - 441
    - CRUM-CIANFLONE NF, AIDS READ, (2006), vol. 16, no. 4, pages 199 - 217
    - SHELBURNE SA ET AL., MEDICINE (BALTIMORE), (2002), vol. 81, no. 3, pages 213 - 227
    - KHATRI BO ET AL., NEUROLOGY, (2009), vol. 72, no. 5, pages 402 - 409
    - MILLER DH ET AL., N ENGL J MED, (2003), vol. 348, no. 1, pages 15 - 23
    - STUVE O ET AL., ARCH NEUROL, (2006), vol. 63, no. 10, pages 1383 - 1387
    - PROF. H.H. HIRSCH, Clinical and Transplantation Virology, INSTITUTE FOR MEDICAL MICROBIOLOGY
    - SWITZERLAND, PROF. K. MUHIEMANN, Clinical Microbiology
    - RYSCHKEWITSCH C ET AL., J VIROL METHODS, (2004), vol. 121, no. 2, pages 217 - 221
    - FELGENHAUER K ET AL., J NEUROL SCI, (1976), vol. 30, no. 1, pages 113 - 128
    - REIBER H, FELGENHAUER K, CLIN CHIM ACTA, (1987), vol. 163, no. 3, pages 319 - 328
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.